[1]
S. Chiorescu, O. A. Andercou, N. O. Grad, and I. A. Mironiuc, “Intraperitoneal Administration of Rosuvastatin Prevents Postoperative Peritoneal Adhesions by Decreasing the Release of Tumor Necrosis Factor”, Medicine and Pharmacy Reports, vol. 91, no. 1, pp. 79-84, Jan. 2018.